ROYAL BANK OF CANADA - PHARMACYTE BIOTECH INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q3 2023$0980.0%0.00%
Q2 2023$0980.0%0.00%
Q1 2023$0980.0%0.00%
Q4 2022$098
-35.1%
0.00%
Q3 2022$0151
+54.1%
0.00%
Q2 2022$0980.0%0.00%
Q1 2022$0980.0%0.00%
Q4 2021$0
-100.0%
98
-85.2%
0.00%
Q3 2021$2,0006620.00%
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ayrton Capital LLC 1,033,130$3,027,0718.27%
K2 PRINCIPAL FUND, L.P. 732,105$2,145,0680.33%
EQUITEC PROPRIETARY MARKETS, LLC 330,694$968,9330.31%
SABBY MANAGEMENT, LLC 97,978$287,0760.25%
FNY Investment Advisers, LLC 31,100$900.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 40,800$119,5440.02%
Aspire Private Capital, LLC 800$2,3440.00%
Schonfeld Strategic Advisors LLC 25,200$73,8360.00%
OSAIC HOLDINGS, INC. 1,758$6,0000.00%
BANK OF AMERICA CORP /DE/ 98$2860.00%
View complete list of PHARMACYTE BIOTECH INC shareholders